Streptococcal Toxic Shock Syndrome
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
PATHOGENS
- Streptococcus pyogenes (Group A, GAS)
- S. pyogenes produces exotoxins SPEA, SPEB, and SPEC.
- These toxins are superantigens capable of activating up to 25% of T cells. Therapy selected to stop toxin production.
- S. pyogenes produces exotoxins SPEA, SPEB, and SPEC.
- Other Streptococcus species (described)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
PATHOGENS
- Streptococcus pyogenes (Group A, GAS)
- S. pyogenes produces exotoxins SPEA, SPEB, and SPEC.
- These toxins are superantigens capable of activating up to 25% of T cells. Therapy selected to stop toxin production.
- S. pyogenes produces exotoxins SPEA, SPEB, and SPEC.
- Other Streptococcus species (described)
There's more to see -- the rest of this entry is available only to subscribers.